drugset / Trial / NCT05568082

A Study to Evaluate the Drug-drug Interaction Effect of Itraconazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

NCT05568082

Phase 1 Completed 14 enrolled Amgen
NaSingle-groupOpen-labelBasic science

Summary

The primary objective of the study is to evaluate the pharmacokinetic (PK) profile of AMG 510 administered alone and in combination with itraconazole in healthy participants.

Timeline

Start
2019-12-03
Primary completion
2019-12-17
Completion
2019-12-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule Oral
Subject Sotorasib Small molecule Oral

Indications

No indication recorded.